NHS Research Scotland

What NHS Research Scotland does

NHS Research Scotland (NRS) is a publicly funded clinical research infrastructure body, established as a partnership of Scottish NHS Boards and the Chief Scientist Office (CSO) of the Scottish Government. Headquartered in Glasgow and founded in 1973, NRS coordinates clinical research delivery across Scotland through 10 clinical research networks, 18 specialty groups, and 4 Commercial Research Delivery Centres (CRDCs) located in Glasgow, Grampian, Lothian, and Tayside. The organisation supports more than 1,600 trials annually with over 61,000 participants, and operates the SHARE register, a consented participant database that has recruited more than 300,000 people for health research.

NRS's operating model is built around institutional coordination of NHS clinical research capacity rather than proprietary technology development. The CRDC hub-and-spoke structure provides commercial sponsors with a single-entry point for Scotland-wide trial delivery, while the Primary Care Research Network and the newly launched Primary Care Research Unit (PERU) extend infrastructure into community and primary care settings. The SHARE register and the 18 specialty groups provide pre-existing patient populations, clinical expertise, and protocol delivery capability that sponsors would otherwise have to assemble board-by-board. The business is not commercial in the conventional sense: it does not sell products or charge per-trial fees in the open market.

Revenue is provided through an annual investment of £50 million from the CSO of the Scottish Government, supplemented by participation in the UK-wide Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) Investment Programme in partnership with the UK Government and the Association of the British Pharmaceutical Industry (ABPI). NRS is a state entity, not investor-backed, with a workforce in the 251–500 employee range. As such, conventional PE/VC/M&A mechanics — equity, valuation, exit — do not apply; the relevant investment lens is funding sustainability, governance risk, and the durability of its statutory mandate within the Scottish NHS.

Name

NHS Research Scotland

Legal name

NHS Research Scotland

Website

https://nhsresearchscotland.org.uk

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

251–500 employees

Short description

NHS Research Scotland is a publicly funded partnership of Scottish NHS Boards and the Scottish Government coordinating clinical research infrastructure across Scotland, supporting over 1,600 trials annually and 61,000 participants through 10 research networks and 4 Commercial Research Delivery Centres.

Ownership category

akta.pro rank

Product category

Clinical Research Coordination Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Clinical research coordination
• Clinical trial delivery
• Research network infrastructure
• Patient recruitment services
• Commercial research delivery

Headquarters

HQ city

Glasgow

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Government Funding: NRS receives annual investment of £50m from the Chief Scientist Office (CSO) of Scottish Government to support and coordinate health research activity across NHS Scotland.
2. VPAG Investment Programme: Funding from the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth agreement between UK Government and ABPI, supporting commercial clinical trial infrastructure.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

NHS Research Scotland coordinates and supports clinical research delivery across NHS Scotland through a network of 10 clinical research networks and 18 specialty groups. It operates four Commercial Research Delivery Centres (CRDCs) in Glasgow, Grampian, Lothian, and Tayside under a hub-and-spoke model to deliver commercial clinical trials, alongside Clinical Research Facilities, Practice Embedded Research Units, the SHARE register (300,000+ participants), and Patient and Public Involvement (PPI) groups.

Product overview

NHS Research Scotland is a national clinical research support network, not a single software product, but rather a coordinated infrastructure comprising multiple integrated services. The core NRS partnership coordinates clinical research across Scottish NHS Boards via 10 clinical research networks and 18 specialty groups. Key infrastructure includes four Commercial Research Delivery Centres (CRDCs) in Glasgow, Grampian, Lothian, and Tayside operating under a hub-and-spoke model, alongside Clinical Research Facilities providing purpose-built environments for patient-oriented research. The portfolio includes the SHARE Register and Biobank (300,000+ participants), Practice Embedded Research Units (PERUs) for primary care, the Neuroprogressive and Dementia Network, and extensive Patient and Public Involvement groups. The VPAG Investment Programme supports commercial clinical trial delivery. These components work together to deliver clinical trials from setup through delivery across Scotland.

Differentiator

Problem solved

Functional benefit

Products and services

• NHS Research Scotland (NRS) Clinical Research Network Core NRS partnership that coordinates clinical research across NHS Scotland through 10 clinical research networks and 18 specialty groups, providing a unified research infrastructure across all 14 territorial health boards.
• Commercial Research Delivery Centres (CRDCs) Four integrated commercial research delivery centres in Glasgow, Grampian, Lothian, and Tayside operating under a hub-and-spoke model to support and accelerate commercial clinical trials, giving commercial sponsors access to NHS patient populations.
• Neuroprogressive and Dementia Network (NDN) Specialty network supporting research into neuroprogressive diseases including Dementia, Parkinson's Disease, Huntington's Disease, Multiple Sclerosis, and Motor Neurone Disease, with sites in Dundee, Edinburgh, Aberdeen, and Glasgow.
• Practice Embedded Research Unit (PERU) A model helping expand opportunities for research participation by transforming how commercial clinical research is delivered in primary and community care settings, including the first unit at Penicuik Medical Practice.
• SHARE Register and Biobank A register of over 300,000 adults and children willing to be invited to participate in medical research projects, using coded data from NHS computer records to identify suitable participants.
• Patient and Public Involvement (PPI) Groups Network of patient and public involvement groups across Scotland covering therapy areas including Ageing, Arthritis, Cardiovascular, Care Homes, Children, Diabetes, Mental Health, Neuroprogressive and Dementia, and others, enabling public input into research design and delivery.
• Permission to Contact Database A register giving patients living with neuroprogressive conditions or dementia in Scotland an opportunity to be contacted about taking part in research projects, with over 950 sign-ups.
• VPAG Investment Programme Partnership with the UK Government and ABPI through the Voluntary Scheme for Branded Medicines Pricing, Access and Growth, expanding commercial clinical trial infrastructure across Scotland.

Quantifiable outcome

• Over 1,600 trials and 61,000+ participants annually
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Nine partnerships are on record, tiered core and secondary.

• UK Government and ABPI (VPAG)coreStrategic or Co-development Partner · 1 January 2024NRS is a key partner in the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth agreement between UK Government and the Association of British Pharmaceutical Industry (ABPI). This agreement includes an investment programme across the four UK nations to strengthen commercial clinical trial delivery, with Scotland receiving funding to expand CRDCs and workforce capacity.
• Scottish Cancer Research Working with Industry ForumsecondaryStrategic or Co-development Partner · 1 January 2015An ongoing collaboration between pharma industry, NHS Scotland, and academics bringing together delegates from NHS, patient representative groups, industry, and academia to showcase Scotland's cancer research capabilities and create opportunities for collaboration.
• Chief Scientist Office (CSO) of Scottish GovernmentcoreStrategic or Co-development PartnerCSO is the government body that funds and oversees NHS Research Scotland, providing £50m annual investment to support and coordinate health research activity across NHS Scotland. CSO provides strategic direction and governance for the NRS partnership.
• NHS Grampian, NHS Greater Glasgow & Clyde, NHS Lothian, NHS TaysidecoreStrategic or Co-development PartnerThe four nodal health boards host the Commercial Research Delivery Centres (CRDCs) and serve as the primary delivery infrastructure for commercial clinical trials in Scotland. Their R&D Directors form part of the NRS Strategy Board.
• ACCORD (University of Edinburgh and NHS Lothian)coreStrategic or Co-development PartnerACCORD is a partnership between the University of Edinburgh and NHS Lothian combining clinical research expertise. The partnership hosts a #Red4Research coffee morning and supports clinical trial delivery.
• Health Science ScotlandsecondaryStrategic or Co-development PartnerAcademic partnership initiative mentioned as part of NHS Research Scotland's collaborative network supporting health science research across Scotland.
• National Institute for Health and Care Research (NIHR)secondaryStrategic or Co-development PartnerNIHR operates the Be Part of Research service in collaboration with devolved administrations including Scotland. This UK-wide research volunteer registry helps match people to suitable health and care studies.
• InnoScot HealthsecondaryOthersInnoScot Health is identified as the Data Controller for the NRS website, handling privacy and data protection matters for the organization's digital presence.
• UK-wide National Contract Value ReviewsecondaryTechnology or IntegrationNRS participates in the UK-wide National Contract Value Review initiative to standardize commercial trial contracts across the four UK nations, improving efficiency and reducing setup timelines.

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Parexel: Global CRO with significant UK presence providing clinical trial management for pharmaceutical sponsors. Comparable as an alternative delivery mechanism for commercial trials that might otherwise use NHS-affiliated networks like NRS.
• IQVIA: Global full-service CRO with extensive commercial clinical trial delivery capability. Overlaps with NRS's CRDC function for industry-sponsored trials but at much larger scale and as a private commercial entity rather than public infrastructure.
• Syneos Health: Large global CRO offering commercial clinical trial delivery and site management services. Operates in the same commercial sponsor space as NRS but as a private-sector full-service provider.
• ICON plc: Major global CRO providing commercial clinical trial management and site activation services across multiple therapeutic areas. Competes with NRS CRDCs for industry-sponsored trial placement in the UK.

Regional players

• Canadian Institutes of Health Research (CIHR): Canada's federal health research funding agency supporting clinical trials and health research networks. International peer at the public-sector clinical research infrastructure level, though operating at a different governance scale.
• ZonMw (Netherlands): Dutch public-sector organisation funding and coordinating health research and clinical trials across the Netherlands — international functional peer given similar government-backed model, though operating in a different national jurisdiction.

Direct peers

• NHS England Commercial Clinical Trials: NHS England's commercial clinical trials programme that competes with NRS CRDCs for industry-sponsored UK trial placements; co-participant in the UK-wide NCVR and VPAG arrangements.
• HSC R&D Division (Northern Ireland): Northern Ireland's equivalent publicly funded research infrastructure, part of the UK-wide VPAG arrangement alongside NRS. Operates with similar scale and remit within a smaller devolved NHS system.
• Health and Care Research Wales: Wales's devolved equivalent, coordinating clinical research infrastructure across NHS Wales with similar Specialty Leads, research delivery networks, and public-sector funding model. Directly comparable in structure and remit to NRS.
• National Institute for Health and Care Research (NIHR): England's equivalent publicly funded clinical research delivery network, coordinating trials across NHS England via 15 Local Clinical Research Networks and the Be Part of Research registry. Direct functional peer given the parallel public-sector model and UK-wide competitive context.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@NHSResearchScotland
• LinkedInlinkedin.com/company/nhsresearchscotland
• Xx.com/NHSResearchScot
• Facebookfacebook.com/NRSBiorepository2016

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NHS Research Scotland